The Significance of IgG to Aspergillus in Non-Cystic Fibrosis Bronchiectasis

C. Huntley (Wolverhampton, United Kingdom), P. Chohan (Wolverhampton, United Kingdom), K. Yip (Wolverhampton, United Kingdom), R. Carter (Wolverhampton, United Kingdom)

Source: International Congress 2019 – Complex respiratory infections in clinical practice
Session: Complex respiratory infections in clinical practice
Session type: Thematic Poster
Number: 4583
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Huntley (Wolverhampton, United Kingdom), P. Chohan (Wolverhampton, United Kingdom), K. Yip (Wolverhampton, United Kingdom), R. Carter (Wolverhampton, United Kingdom). The Significance of IgG to Aspergillus in Non-Cystic Fibrosis Bronchiectasis. 4583

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015

Impact of Anemia On Clinically Stable Adult Non-cystic Fibrosis Bronchiectasis
Source: International Congress 2018 – Management of bronchiectasis and large airway diseases
Year: 2018


Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019


Evaluation of Serum Chitotriozidase Activity and C - reactive protein and Albumin Ratio in Cystic Fibrosis and Bronchopulmonary Dysplasia
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


Relationship between Neutrophilic Airway Inflammation and Airway Colonisation in non-Cystic Fibrosis Bronchiectasis
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Epidemiology of Idiopathic Pulmonary Fibrosis in Australia
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Characterize Idiopathic Pulmonary Fibrosis using Respiratory Oscillometry
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – M-health/e-health I
Year: 2019


Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018

Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary
Source: Guideline 2015
Year: 2015

Nitrofurantoin Induced Pulmonary Fibrosis: A Case Series
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021


Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF)
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Microbiome in Cystic Fibrosis Exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019

Bronchial Lavage Exosome miRNA Correlates to Metabolic Disturbance in Patients with Pulmonary Acinetobacter Baumannii Infection
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019